VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 404 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2016. The put-call ratio across all filers is 0.94 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $26,447,000 | +38.5% | 1,139,760 | -5.1% | 0.03% | +30.4% |
| Q1 2018 | $19,093,000 | -28.2% | 1,200,860 | -5.8% | 0.02% | -20.7% |
| Q4 2017 | $26,589,000 | +45.5% | 1,274,660 | 0.0% | 0.03% | +38.1% |
| Q3 2017 | $18,271,000 | -16.0% | 1,274,660 | +1.9% | 0.02% | -19.2% |
| Q2 2017 | $21,748,000 | +50.0% | 1,251,060 | -4.7% | 0.03% | +44.4% |
| Q1 2017 | $14,500,000 | -45.7% | 1,312,660 | -28.7% | 0.02% | -57.1% |
| Q4 2016 | $26,689,000 | -40.3% | 1,842,060 | +1.1% | 0.04% | -41.7% |
| Q3 2016 | $44,730,000 | +21.6% | 1,822,560 | -0.6% | 0.07% | +20.0% |
| Q2 2016 | $36,796,000 | -17.9% | 1,833,860 | +3.5% | 0.06% | -26.8% |
| Q1 2016 | $44,834,000 | -69.2% | 1,771,060 | +23.5% | 0.08% | -76.7% |
| Q4 2015 | $145,370,000 | -43.4% | 1,434,360 | -0.5% | 0.35% | -46.6% |
| Q3 2015 | $256,684,000 | -9.8% | 1,442,260 | +12.9% | 0.66% | -10.7% |
| Q2 2015 | $284,548,000 | +19.4% | 1,276,960 | +5.4% | 0.74% | +16.0% |
| Q1 2015 | $238,286,000 | +68.7% | 1,211,860 | +23.0% | 0.64% | +20.2% |
| Q4 2014 | $141,268,000 | +13.1% | 984,960 | +3.5% | 0.53% | +10.4% |
| Q3 2014 | $124,867,000 | -0.7% | 951,460 | -4.4% | 0.48% | +3.0% |
| Q2 2014 | $125,749,000 | -6.4% | 995,160 | -2.2% | 0.46% | -11.8% |
| Q1 2014 | $134,350,000 | +12.0% | 1,018,060 | -0.4% | 0.53% | +12.6% |
| Q4 2013 | $119,924,000 | +13.7% | 1,022,460 | +1.2% | 0.47% | +6.6% |
| Q3 2013 | $105,454,000 | +26.6% | 1,009,960 | +4.7% | 0.44% | +19.9% |
| Q2 2013 | $83,276,000 | – | 965,000 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,577,892 | $994,984,000 | 31.62% |
| Ruane, Cunniff & Goldfarb | 33,922,192 | $6,051,041,000 | 31.06% |
| LeVasseur Capital Partners LLC | 162,394 | $28,968,000 | 29.76% |
| FARLEY CAPITAL L.P. | 192,130 | $34,272,000 | 27.18% |
| Pershing Square Capital Management | 19,473,933 | $3,473,760,000 | 24.90% |
| Arrow Capital Management, LLC | 109,461 | $19,525,000 | 16.53% |
| Marble Arch Investments | 1,196,900 | $213,503,000 | 16.43% |
| Tesuji Partners | 1,368,040 | $244,414,000 | 15.82% |
| ValueAct Holdings | 14,994,261 | $2,674,676,000 | 15.55% |
| Hound Partners | 3,898,648 | $695,441,000 | 15.04% |